About Voronoi
voronoi, a leading biotech in south korea egfr-exon20ins lisenced out to oric parmaceuticals in 2020 ret-fusion lisenced out to inno.n in 2021 anticipated upcoming ipo on kosdaq for ... Read more
voronoi, a leading biotech in south korea egfr-exon20ins lisenced out to oric parmaceuticals in 2020 ret-fusion lisenced out to inno.n in 2021 anticipated upcoming ipo on kosdaq for ... Read more